Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable condition, she will undergo surgery and radiation treatment while continuing ...

Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...

Over the weekend Shane Gillis made his return to "Saturday Night Live" as host for the second time since he was fired from ...

Today, Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer.

Plus: All the news and watercooler chat from Fortune. Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis ...

Accenture Chief Executive Officer Julie Sweet has been diagnosed with early-stage breast cancer and the treatment is likely to last 12-16 weeks, Moneycontrol has learnt. “I was very recently ...

Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer and the treatment is likely to last 12-16 weeks, according to a Moneycontrol report. However, the CEO will continue to ...

Today, Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company’s Chair and Chief Executive Officer. In a message ...

Accenture Chief Executive Officer (CEO) Julie Sweet has disclosed a health update in an internal mail to employees. The CEO has been diagnosed with early-stage breast cancer, with treatment expected ...